β-Adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure

J Biol Chem. 2017 Jul 14;292(28):11815-11828. doi: 10.1074/jbc.M117.777748. Epub 2017 May 17.

Abstract

In liver steatosis (i.e. fatty liver), hepatocytes accumulate many large neutral lipid storage organelles known as lipid droplets (LDs). LDs are important in the maintenance of energy homeostasis, but the signaling mechanisms that stimulate LD metabolism in hepatocytes are poorly defined. In adipocytes, catecholamines target the β-adrenergic (β-AR)/cAMP pathway to activate cytosolic lipases and induce their recruitment to the LD surface. Therefore, the goal of this study was to determine whether hepatocytes, like adipocytes, also undergo cAMP-mediated lipolysis in response to β-AR stimulation. Using primary rat hepatocytes and human hepatoma cells, we found that treatment with the β-AR agent isoproterenol caused substantial LD loss via activation of cytosolic lipases adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL). β-Adrenergic stimulation rapidly activated PKA, which led to the phosphorylation of ATGL and HSL and their recruitment to the LD surface. To test whether this β-AR-dependent lipolysis pathway was altered in a model of alcoholic fatty liver, primary hepatocytes from rats fed a 6-week EtOH-containing Lieber-DeCarli diet were treated with cAMP agonists. Compared with controls, EtOH-exposed hepatocytes showed a drastic inhibition in β-AR/cAMP-induced LD breakdown and the phosphorylation of PKA substrates, including HSL. This observation was supported in VA-13 cells, an EtOH-metabolizing human hepatoma cell line, which displayed marked defects in both PKA activation and isoproterenol-induced ATGL translocation to the LD periphery. In summary, these findings suggest that β-AR stimulation mobilizes cytosolic lipases for LD breakdown in hepatocytes, and perturbation of this pathway could be a major consequence of chronic EtOH insult leading to fatty liver.

Keywords: G protein-coupled receptor (GPCR); adipose triglyceride lipase (ATGL); adrenergic receptor; alcohol; cyclic AMP (cAMP); fatty liver; hepatocyte; lipid droplet.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adrenergic beta-Agonists / pharmacology*
  • Animals
  • Cell Line, Tumor
  • Cells, Cultured
  • Cyclic AMP / agonists*
  • Cyclic AMP / metabolism
  • Cyclic AMP-Dependent Protein Kinases / chemistry
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Enzyme Activation / drug effects
  • Fatty Liver, Alcoholic / metabolism*
  • Fatty Liver, Alcoholic / pathology
  • Female
  • Hepatocytes / cytology
  • Hepatocytes / drug effects*
  • Hepatocytes / metabolism
  • Hepatocytes / pathology
  • Humans
  • Lipase / chemistry
  • Lipase / metabolism
  • Lipid Droplets / drug effects
  • Lipid Droplets / metabolism
  • Lipid Droplets / pathology
  • Lipolysis / drug effects*
  • Male
  • Phosphorylation / drug effects
  • Protein Processing, Post-Translational / drug effects
  • Protein Transport / drug effects
  • Rats
  • Receptors, Adrenergic, beta / chemistry
  • Receptors, Adrenergic, beta / metabolism*
  • Second Messenger Systems / drug effects*
  • Sterol Esterase / chemistry
  • Sterol Esterase / metabolism

Substances

  • Adrenergic beta-Agonists
  • Receptors, Adrenergic, beta
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • Sterol Esterase
  • Lipase
  • PNPLA2 protein, rat